SCHEMBL20034867

SCHEMBL20034867

CCS(=O)(=O)NC(C)C(C)C

nearest known ligand 0.35

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14558217 1.00 MAPT (0.35) MAPT
SCHEMBL24571688 0.82 ACACB (0.36)
SCHEMBL799192 0.77
SCHEMBL9665535 0.77 MAPT (0.30) MAPT
SCHEMBL9667661 0.75 CA2 (0.33) MAPT
SCHEMBL19115187 0.75
SCHEMBL3650415 0.74
SCHEMBL28699695 0.74 CA12 (0.31) MAPT
SCHEMBL24723653 0.74 CYP3A4 (0.31) MAPT
SCHEMBL21592509 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9938301-B2 Dihydropyrimido fused ring derivative as HBV inhibitor QILU PHARMACEUTICAL CO., LTD. (CN) 2018-04-10 US disclosed